These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 27718294)
61. Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome. Ergenoglu M; Yildirim N; Yildirim AG; Yeniel O; Erbas O; Yavasoglu A; Taskiran D; Karadadas N Reprod Sci; 2015 Aug; 22(8):942-7. PubMed ID: 25667201 [TBL] [Abstract][Full Text] [Related]
62. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan. Tremellen K; Zander-Fox D Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428 [TBL] [Abstract][Full Text] [Related]
63. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome. Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005 [TBL] [Abstract][Full Text] [Related]
64. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women. Wachs DS; Coffler MS; Malcom PJ; Chang RJ J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061 [TBL] [Abstract][Full Text] [Related]
65. Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients. Köninger A; Koch L; Enekwe A; Birdir C; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B Gynecol Endocrinol; 2015 Jan; 31(1):26-30. PubMed ID: 25222840 [TBL] [Abstract][Full Text] [Related]
66. Does AMH Reflect Follicle Number Similarly in Women with and without PCOS? Christiansen SC; Eilertsen TB; Vanky E; Carlsen SM PLoS One; 2016; 11(1):e0146739. PubMed ID: 26799212 [TBL] [Abstract][Full Text] [Related]
67. Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone. Ikeda K; Baba T; Morishita M; Honnma H; Endo T; Kiya T; Saito T J Ovarian Res; 2014; 7():46. PubMed ID: 24851135 [TBL] [Abstract][Full Text] [Related]
68. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947 [TBL] [Abstract][Full Text] [Related]
69. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527 [TBL] [Abstract][Full Text] [Related]
70. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369 [TBL] [Abstract][Full Text] [Related]
71. Anti-Müllerian hormone and polycystic ovary syndrome. Bhide P; Homburg R Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():38-45. PubMed ID: 27103234 [TBL] [Abstract][Full Text] [Related]
72. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. Sir-Petermann T; Codner E; Maliqueo M; Echiburú B; Hitschfeld C; Crisosto N; Pérez-Bravo F; Recabarren SE; Cassorla F J Clin Endocrinol Metab; 2006 Aug; 91(8):3105-9. PubMed ID: 16720659 [TBL] [Abstract][Full Text] [Related]
73. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Tokmak A; Kokanali D; Timur H; Kuntay Kokanali M; Yilmaz N Gynecol Endocrinol; 2016 Nov; 32(11):926-930. PubMed ID: 27275748 [TBL] [Abstract][Full Text] [Related]
74. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605 [TBL] [Abstract][Full Text] [Related]
76. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome. Carlsen SM; Vanky E; Fleming R Hum Reprod; 2009 Jul; 24(7):1732-8. PubMed ID: 19342396 [TBL] [Abstract][Full Text] [Related]
77. Anti-Müllerian Hormone Accelerates Pathological Process of Insulin Resistance in Polycystic Ovary Syndrome Patients. Li XJ; Wang H; Lu DY; Yu TT; Ullah K; Shi XY; Shen YH; Fei XY; Lin ZY; Huang HF; Lin XH Horm Metab Res; 2021 Aug; 53(8):504-511. PubMed ID: 34384107 [TBL] [Abstract][Full Text] [Related]
78. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome. Szafarowska M; Dziech E; Kaleta B; Kniotek M; Rogowski A; Segiet-Święcicka A; Jerzak M J Assist Reprod Genet; 2019 Jun; 36(6):1281-1289. PubMed ID: 31089932 [TBL] [Abstract][Full Text] [Related]
79. Expression of the anti-Mullerian hormone, kisspeptin 1, and kisspeptin 1 receptor in polycystic ovary syndrome and controlled ovarian stimulation rat models. Risvanli A; Ocal H; Timurkaan N; Ipek P; Seker I; Karabulut B Bosn J Basic Med Sci; 2020 Feb; 20(1):37-43. PubMed ID: 31782699 [TBL] [Abstract][Full Text] [Related]
80. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. Crisosto N; Codner E; Maliqueo M; Echiburú B; Sánchez F; Cassorla F; Sir-Petermann T J Clin Endocrinol Metab; 2007 Jul; 92(7):2739-43. PubMed ID: 17488788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]